$MNST

Beverages, Alcohol, and Tobacco Stocks Q2 Teardown: Monster (NASDAQ:MNST) Vs The Rest

Vita Coco raised full-year guidance but its stock fell 22.1% post-earnings. Celsius reported $817.9M revenue, missing estimates, and its stock dropped 2%. Philip Morris reported $11.19B revenue, beating estimates, and its stock rose 7.1%. Boston Beer's revenue fell 3.3%, missing EPS estimates, and its stock declined 2.3%.

Original reporting
Published Oct 12, 2026, 10:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 10:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Beverages, Alcohol, and Tobacco Stocks Q2 Teardown: Monster (NASDAQ:MNST) Vs The Rest — source image
Decision brief

The 30-second read

$MNSTBearishLow
01

Why it matters

Overall, the piece provides a mixed view with one clear winner (PM) and three laggards, offering limited actionable insight.

02

Market read

Provides a snapshot of sector performance but no new data beyond previously released earnings.

03

What to watch

Potential cost pressures and macro consumer sentiment shifts are not detailed.

Relevance 4/10Novelty 2/10Timing: none

Background

The article recaps Q2 earnings for four consumer beverage/alcohol/tobacco companies, noting revenue growth, earnings beats/misses, and stock price reactions.

Company-level read

Ticker impact

$MNSTBearishHigh confidence
Context

Monster (MNST) stock is down 22.1% since reporting its Q2 results.

Expected impact

likely continued pressure as investors digest the weak reaction.

Evidence & confidence

The article notes a 22.1% drop, indicating strong sell pressure.

$CELHBearishHigh confidence
Context

Celsius (CELH) reported revenue up 10.6% YoY but missed earnings estimates, stock down 2%.

Expected impact

likely modest further decline as analysts reassess forecasts.

Evidence & confidence

Missed EPS and EBITDA estimates are highlighted as the catalyst.

$PMBullishHigh confidence
Context

Philip Morris (PM) posted revenue up 10.4% YoY and beat earnings estimates, stock up 7.1%.

Expected impact

potential continued rally if momentum persists.

Evidence & confidence

Analyst beat and price gain indicate positive market reaction.

$SAMBearishHigh confidence
Context

Boston Beer (SAM) revenue down 3.3% YoY and missed EPS estimates, stock down 2.3%.

Expected impact

likely modest further decline as investors weigh miss.

Evidence & confidence

EPS miss and revenue decline are cited as the downside drivers.

Market effects

Highlights mixed performance across beverage, alcohol, and tobacco sectors.

U.S. consumer discretionary stocks see varied reactions.

Limited; primarily U.S. listed consumer brands.

Counterpoint

Despite price drops, the underlying business fundamentals may be stronger than implied.

Key entities

  • Monster Beverage

    U.S.-listed beverage maker (MNST).

  • Celsius Holdings

    Energy drink maker (CELH).

  • Philip Morris International

    Tobacco giant (PM).

  • Boston Beer Company

    Craft brewer (SAM).

Related articles

$PMMed

Philip Morris Just Raised Its Dividend 8.8%. Can It Afford Another Increase?

Philip Morris International (PM) raised its quarterly dividend by 8.8% to $1.60, increasing the annualized rate to $6.40 and yielding 3.1%. The company has consistently raised dividends since 2008, with recent increases funded by strong cash flow. PM's adjusted EPS guidance for 2026 is $8.26 to $8.41, and dividends consume about 76-77% of this range. Revenue grew 10.4% in Q2, driven by smoke-free products.

$PMHigh

US FDA authorizes lower-risk claim for 20 ZYN nicotine pouches

The US FDA authorized 20 ZYN nicotine pouches by Swedish Match USA (PMI US) to carry a modified-risk claim, stating their use instead of cigarettes lowers the risk of several smoking-related diseases. This is the first such authorization for nicotine pouches. The decision follows a scientific review and is valid for five years with mandatory market monitoring. PMI US CEO Stacey Kennedy welcomed the decision, highlighting access to science-based information for adult nicotine consumers.

$PEPMed

Delhi HC Relief Gives Campa, PepsiCo & Monster Breathing Room In FSSAI Labelling Row

The Delhi High Court granted interim relief to Reliance Consumer Products, PepsiCo, and Monster Beverage, allowing them to continue using the term 'energy drink' on their high-caffeine beverages. The court stayed FSSAI's directive pending broader legal challenges, citing lack of prior notice and commercial impact. Reliance reported significant inventory and distribution disruptions due to the directive.